Published time: 20 May 2020
Authors: L.Bertoletti, F.Couturaud, D.Montani, F.Parent, O.Sanche
Keywords: Venous thromboembolism, COVID-19, Coronavirus disease, SARS-CoV-2, Pulmonary embolism, Venous thromboembolic disease
The outbreak of 2019 novel Coronavirus disease (COVID-19) is deeply weakening the whole world, and particularly, the healthcare systems. Respiratory physicians are part of the first-line healthcare providers involved in the fight against the severe acute respiratory syndrome Coronavirus 2 [SARS-CoV-2] whose effects on the human body are still poorly understood. In addition to severe lung parenchymal damage, which is the main cause of the disease severity, a particular interest has been raised regarding venous thromboembolic (VTE) diseases.
Venous thromboembolism and COVID-19